Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 32 | $12,692,131 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 27 Jan 2025 20:28 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 23 Jan 2025 | Sale | 16,217 | 40.08 | 649,977 | D |
| 27 Jan 2025 20:28 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 24 Jan 2025 | Sale | 22,468 | 40.2 | 903,214 | D |
| 27 Jan 2025 20:28 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 27 Jan 2025 | Sale | 15,166 | 40.46 | 613,616 | D |
| 27 Jan 2025 20:28 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 27 Jan 2025 | Sale | 1,149 | 41.07 | 47,189 | D |
| 19 Dec 2024 18:57 | XENE | Xenon Pharmaceuticals Inc | AULIN SHERRY | Chief Financial Officer | 18 Dec 2024 | Sale | 7,199 | 41.23 | 296,815 | D |
| 19 Dec 2024 18:57 | XENE | Xenon Pharmaceuticals Inc | AULIN SHERRY | Chief Financial Officer | 18 Dec 2024 | Sale | 11,510 | 41.19 | 474,097 | D |
| 22 Nov 2024 19:48 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 22 Nov 2024 | Sale | 2,851 | 41.11 | 117,205 | D |
| 22 Nov 2024 19:48 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 22 Nov 2024 | Sale | 2,040 | 41.05 | 83,742 | D |
| 11 Mar 2024 20:09 | XENE | Xenon Pharmaceuticals Inc | GAROFALO ELIZABETH A. | Director | 08 Mar 2024 | Sale | 2,092 | 45.69 | 95,583 | D |
| 08 Mar 2024 17:31 | XENE | Xenon Pharmaceuticals Inc | ROBIN SHERRINGTON | EVP, Strategy & Innovation | 07 Mar 2024 | Sale | 6,118 | 46.3 | 283,263 | D |
| 08 Mar 2024 17:31 | XENE | Xenon Pharmaceuticals Inc | ROBIN SHERRINGTON | EVP, Strategy & Innovation | 07 Mar 2024 | Sale | 1,019 | 46.15 | 47,027 | D |
| 08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 2,000 | 46.2012 | 92,402 | D |
| 08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 5,000 | 46.3025 | 231,512 | D |
| 08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 5,000 | 46.25 | 231,250 | D |
| 08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 1,000 | 46.45 | 46,450 | D |
| 15 Dec 2023 21:50 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 14 Dec 2023 | Sale A | 7,598 | 41.05 | 311,898 | I |
| 15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 7,598 | 41.05 | 311,898 | I |
| 15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 3,977 | 39.84 | 158,444 | D |
| 15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 2,303 | 39.1 | 90,047 | D |
| 15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 5,100 | 38.94 | 198,594 | D |
| 24 Aug 2023 16:33 | XENE | Xenon Pharmaceuticals Inc | SVORONOS DAWN | Director | 24 Aug 2023 | Sale | 25,000 | 38.7 | 967,500 | D |
| 01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 01 Jun 2023 | Sale | 24,255 | 38.78 | 940,609 | D |
| 01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 01 Jun 2023 | Sale | 7,458 | 38.97 | 290,638 | D |
| 01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 31 May 2023 | Sale | 26,856 | 38.69 | 1,039,059 | D |
| 01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 31 May 2023 | Sale | 23,670 | 38.81 | 918,633 | D |
| 01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 31 May 2023 | Sale | 12,000 | 38.53 | 462,360 | D |
| 01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 30 May 2023 | Sale | 19,000 | 39.9 | 758,100 | D |
| 01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 30 May 2023 | Sale | 18,006 | 38.63 | 695,572 | D |
| 26 May 2023 19:10 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 24 May 2023 | Sale | 1,407 | 41.49 | 58,376 | D |
| 26 May 2023 19:10 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 24 May 2023 | Sale | 13,179 | 41.37 | 545,215 | D |
| 26 May 2023 19:10 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 24 May 2023 | Sale | 17,069 | 41.44 | 707,339 | D |
| 24 Mar 2023 19:18 | XENE | Xenon Pharmaceuticals Inc | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | 24 Mar 2023 | Sale | 700 | 35.01 | 24,507 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)